Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

OrthoPediatrics Corp. - Common Stock (NQ:KIDS)

20.49 -0.48 (-2.29%)
Streaming Delayed Price Updated: 3:12 PM EDT, Apr 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about OrthoPediatrics Corp. - Common Stock

< Previous 1 2 3 Next >
OrthoPediatrics Corp. Expands Scoliosis Portfolio with Launch of VerteGlide™ System
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. to Participate in the 24th Annual Needham Virtual Healthcare Conference
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Named One the 2025 Best Places to Work in Indiana
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Joins Crossroads Pediatric Device Consortium to Advance Pediatric Medical Device Innovation
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Announces Distribution Agreement with Thrive Orthopedics LLC
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Year 2024 and Issues 2025 Financial Guidance
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Announces Expansion of Specialty Bracing Division
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Expands Specialty Bracing Portfolio with Two New Products
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. to Host Educational and Networking Events at 20th Annual International Pediatric Orthopaedic Symposium (IPOS)
Continues IPOS Corporate Partnership as Emerald-Level Sponsor 
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Expands Specialty Bracing Portfolio with DF2® Brace
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. to Participate in Upcoming Conferences
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Reports Third Quarter 2024 Financial Results and Increases Full Year 2024 Revenue Guidance
Record Third Quarter 2024 Revenue Increased 37% Year-over-Year 
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. to Report Third Quarter 2024 Financial Results on November 7, 2024
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Announces Launch of Enabling Technologies Division
Additional details to be discussed during the Company’s Investor Day today, September 12, 2024 
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. to Host Investor Day on September 12, 2024
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Reports Second Quarter 2024 Financial Results and Reaffirms Full Year 2024 Revenue Guidance
Record Second Quarter 2024 Revenue Increased 33% Year-over-Year 
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Announces Private Financing
Term Loan and Private Placement of Convertible Notes Will Provide Up To $100 Million of Capital 
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. to Report Second Quarter 2024 Financial Results on August 6, 2024
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. to Participate in the Truist Securities MedTech Conference
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Continued Leading Sponsorship at 2024 EPOSNA Annual Meeting
Reinforced Long-Term Commitment as Emerald Sponsor 
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Reports First Quarter 2024 Financial Results and Increases Full Year 2024 Revenue Guidance
First Quarter 2024 Revenue Increased 41% Year-over-Year 
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Receives “Breakthrough Device” Designation from FDA for eLLi™ Growing Rod System for Pediatric Patients with Scoliosis
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. to Report First Quarter 2024 Financial Results on May 7, 2024
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. to Highlight its Pediatric Scoliosis Solutions at 8th Annual International Children’s Spine Symposium (ICSS)
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results
Record full year 2023 revenue of $148.7 million increased 22% compared to prior year 
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Launches New RESPONSE Rib and Pelvic Fixation System for EOS Scoliosis
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Named One of the 2024 Best Places to Work in Indiana
From OrthoPediatrics Corp.
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.